Sign Up Today and Learn More About Dante Labs Stock
Invest in or calculate the value of your shares in Dante Labs or other pre-IPO companies through EquityZen's platform.
Dante Labs Stock (DANL)
Dante Labs is a genomic company helping rare disease patients end their undiagnosed Odyssey thanks to whole genome sequencing
About Dante Labs Stock
Founded
2016
Headquarters
New York, NY, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Dante Labs is a genetic testing and data analysis company specialized in Whole Genome Sequencing. Our mission is to make advanced genetics accessible to everyone. We help rare disease patients end their undiagnosed Odyssey thanks to whole genome sequencing.
Dante Labs Press Mentions
Stay in the know about the latest news on Dante Labs
AI In Genomics Market is Expected to Reach $2.0 Billion ...
digitaljournal • Dec 22, 2023
Investing In AI, With John Cassidy
forbes • Dec 22, 2023
How Dante Labs Makes Genomic Testing Available to People Everywhere
newstoday • Feb 08, 2023
How Dante Labs Is Using Technology to Scale Genomic Testing Capabilities
london-post • Feb 08, 2023
How Dante Labs Empowers Consumers With Personalised Genomic Testing
bmmagazine • Feb 08, 2023
Dante Labs Management
Leadership team at Dante Labs
CTO
Mattia Capulli
CEO
Andrea Riposati
Join now and verify your accreditation status to gain access to:
- Dante Labs Current Valuation
- Dante Labs Stock Price
- Dante Labs Management
- Available deals in Dante Labs and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Dante Labs Cap Table and Funding History by Share Class and Liquidity Preferences
- Dante Labs Revenue and Financials
- Dante Labs Highlights
- Dante Labs Business Model
- Dante Labs Risk Factors
- Dante Labs Research Report from SACRA Research
Trading Dante Labs Stock
How to invest in Dante Labs stock?
Accredited investors can buy pre-IPO stock in companies like Dante Labs through EquityZen funds. These investments are made available by existing Dante Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Dante Labs stock?
Shareholders can sell their Dante Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
